Halyard Health (HYH) Misses Q3 EPS by 20c; Boosts EPS Outlook

Halyard Health (NYSE: HYH) reported Q3 EPS of $0.19, $0.20 worse than the analyst estimate of $0.39. Revenue for the quarter came in at $398 million versus the consensus estimate of $387.64 million.

GUIDANCE:

Halyard Health sees FY2016 EPS of $1.87-$1.97, versus prior guidance of $1.70-$1.90 and the consensus of $1.82.

For earnings history and earnings-related data on Halyard Health (HYH) click here.

You May Also Be Interested In

• Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
• BitFuFu Inc. (FUFU) Misses Q2 EPS by 13c
• Is Treasury selloff a major issue for stock market bulls?